Riskpilot← Back to searchSign inGet full accessPetMeta Labs Oy
OYActiveY-tunnus 3176406-2Mannerheimintie 164-ADiagnostic imaging services and medical laboratory activities · NACE 8691Est. 20201 employees
Revenue 2025
EUR 4K
-106% vs 2024
EBITDA margin
-1209.5%
+55% vs 2024
Equity ratio
82.1%
Financial strength
Net profit 2025
EUR -50K
+55% vs 2024
| Revenue | EUR 4K | -106% |
| EBITDA | EUR -50K | +55% |
| Net profit | EUR -50K | +55% |
| Total assets | EUR 360K | +7% |
| Equity | EUR 296K | +7% |
| Employees | 1 | — |
Legal name
PetMeta Labs Oy
Y-tunnus number
3176406-2
Legal form
Osakeyhtiö
NACE code
8691 · Diagnostic imaging services and medical laboratory activities
Founded
9. joulukuuta 2020
Share capital
EUR 0
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Toimitusjohtaja yksin
Company purpose
Yrityksen toimiala on eläimille tehtävät laboratoriotutkimukset, eläimille tehtäviin laboratoriotutkimuksiin liittyvä luonnontieteellinen ja tekninen laitteisto-, ohjelmisto- ja palveluliiketoiminta sekä laskennalliseen tekniikkaan perustuvien analyysimenetelmien ja -sovellusten kehittäminen eläimille tehtäviin laboratoriotutkimuksiin liittyen. Lisäksi yritys kehittää tietokoneohjelmistoja ja tarjoaa koulutus- sekä konsultointipalveluita edellä mainituilla alueilla.
Address
Mannerheimintie 164-A
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | −36 | −178 | −64 | 4 |
| Staff expenses | −27 | −19 | −11 | 2 |
| EBITDA | −102 | −234 | −110 | −50 |
| Depreciation & amort. | −0 | −0 | −0 | −0 |
| EBIT | −102 | −234 | −110 | −50 |
| Net financials | −0 | 0 | −0 | 0 |
| Profit before tax | −102 | −234 | −110 | −50 |
| Tax | −0 | −0 | −0 | −0 |
| Net profit | −102 | −234 | −110 | −50 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 242 | 242 | 337 | 360 |
| Equity | 218 | 218 | 276 | 296 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 24 | 24 | 61 | 64 |
| Total debt | 24 | 24 | 61 | 64 |
EBITDA margin
-1209.5%
This company
15.8%
Market median
-7755% vs market
20222025
Equity ratio
82.1%
This company
38.2%
Market median
+115% vs market
20222025
Return on equity
-16.8%
This company
18.4%
Market median
-191% vs market
20222025
Net profit margin
-1209.1%
This company
8.1%
Market median
-15027% vs market
20222025
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
20222025
Debt / equity
0.22×
This company
0.62×
Market median
+65% vs market
20222025
- Annual report 2025Filed via PRH / YTJ · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via PRH / YTJ · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via PRH / YTJ · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via PRH / YTJ · Period 2021-07-01 – 2022-06-30
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
| Audit | 2021 – 2023 | |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairperson | 2021 | |
| Board of Directors | 2021 | |
| Board of Directors | 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of PetMeta Labs Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Valtteri Matti Eemeli Helenius | Audit | 0 companies |
| Hannes Tapani Lohi | Chairperson | 0 companies |
| Teemu Pentti Suna | Board of Directors | 0 companies |
| Matti Aulis Koskelo | Board of Directors | 0 companies |